XT
RANI icon

XTX Topco’s Rani Therapeutics RANI Stock Holding History

XTX Topco’s Portfolio RANI Stock Details RANI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.9K Buy
+16,959
New +$15K ﹤0.01% 3990
2025
Q4 		– Sell
-44,077
Closed -$22K – 3701
2025
Q3 		$22K Buy
+44,077
New +$23K ﹤0.01% 2310
2025
Q2 		– Sell
-10,996
Closed -$13.9K – 3020
2025
Q1 		$13.9K Sell
10,996
-1,894
-15% -$2.8K ﹤0.01% 2204
2024
Q4 		$17.7K Buy
+12,890
New +$27.1K ﹤0.01% 2058

Other funds holding RANI

SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LP
Longaeva Partners Chicago, Illinois $4.58B AUM 43.91% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $433M AUM 8.59% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

XTX Topco's RANI Position: Q2 2026 in Review

XTX Topco opened a new position in Rani Therapeutics (RANI) in Q2 2026: 16,959 shares worth $12.9K. The stake represents ﹤0.01% of the portfolio and ranks #3990 among its holdings. This is a return to the name: XTX Topco previously reported a position in RANI as recently as Q3 2025.

XTX Topco first reported a position in RANI in Q4 2024 and has held it in 4 quarters since. The position peaked at $22K in Q3 2025. 68 funds tracked by Wall St. Rank hold RANI as of Q2 2026.

  • XTX Topco held 16,959 shares of Rani Therapeutics worth $12.9K as of Q2 2026.
  • Rani Therapeutics was a new XTX Topco position in Q2 2026.
  • Rani Therapeutics made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #3990 holding.
  • XTX Topco first reported a position in Rani Therapeutics in Q4 2024 and has held it in 4 quarters since.
  • XTX Topco's Rani Therapeutics position peaked at $22K in Q3 2025.
  • 68 funds tracked by Wall St. Rank held Rani Therapeutics as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.